C. Karanikiotis

发表

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.

C. Papadimitriou, T. Economopoulos, H. Kalofonos, 2008, European journal of cancer.

Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer

I. Tentes, V. Manolopoulos, S. Markakidis, 2006, Langenbeck's Archives of Surgery.

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

U. Dafni, H. Gogas, C. Markopoulos, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

World Journal of Surgical Oncology Open Access Large Bilateral Adrenal Metastases in Non-small Cell Lung Cancer

S. Markakidis, Apostolos A Tentes, C. Karanikiotis, 2022 .

Protein expression patterns of cell cycle regulators in operable breast cancer

G. Lazaridis, C. Papadimitriou, G. Aravantinos, 2017, PloS one.

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

D. Yannoukakos, H. Gogas, C. Markopoulos, 2008, Breast Cancer Research and Treatment.

Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy – data from the CHOICE study

S. Van Belle, T. Wheeler, A. Galid, 2011, Current medical research and opinion.

A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice

J. Aerts, S. Van Belle, T. Wheeler, 2012, Current medical research and opinion.

Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer.

G. Georgiadis, S. Markakidis, A. Tentes, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Radical lymph node resection of the retroperitoneal area for left-sided colon cancer

A. Tentes, C. Karanikiotis, C. Mirelis, 2007, Langenbeck's Archives of Surgery.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

A. Charchanti, H. Gogas, G. Aravantinos, 2022, Cancers.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

M. Dimopoulos, E. Giannoulatou, H. Gogas, 2016, Oncotarget.

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

M. Dimopoulos, U. Dafni, H. Gogas, 2012, Breast Cancer Research and Treatment.

Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial

M. Dimopoulos, H. Gogas, G. Lazaridis, 2018, PloS one.

A novel chromatographic method for Ep-CAM mRNA detection in peripheral blood and bone marrow of patients with metastatic colorectal cancer.

G. Fountzilas, I. Skiadas, M. Karina, 2005, Anticancer research.

HLA Class II Alleles and the Presence of Circulating Epstein-Barr Virus DNA in Greek Patients with Nasopharyngeal Carcinoma

T. Economopoulos, G. Fountzilas, A. Nikolaou, 2008, Strahlentherapie und Onkologie.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

M. Dimopoulos, U. Dafni, N. Pavlidis, 2013, BMC Cancer.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy

M. Dimopoulos, H. Gogas, R. Wirtz, 2018, Cancer medicine.

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy

H. Gogas, R. Wirtz, C. Markopoulos, 2017, Translational oncology.

Induction Chemotherapy with Cisplatin, Epirubicin, and Paclitaxel (CEP), Followed by Concomitant Radiotherapy and Weekly Paclitaxel for the Management of Locally Advanced Nasopharyngeal Carcinoma

G. Fountzilas, A. Kalogera‐Fountzila, N. Zamboglou, 2005, Strahlentherapie und Onkologie (Print).

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2011, BMC medicine.

Febrile neutropenia (FN) and pegfilgrastim prophylaxis in breast cancer and non-Hodgkin’s lymphoma patients receiving high (> 20%) FN-risk chemotherapy: results from a prospective observational study

S. Wetten, M. Wojtukiewicz, M. Šmakal, 2018, Supportive Care in Cancer.

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

M. Dimopoulos, U. Dafni, N. Pavlidis, 2014, BMC Cancer.

WPA Bulletin on Depression WPA Bulletin on Depression

G. Lenzi, M. Altieri, K. Fountoulakis, 2007 .

Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)

C. Papadimitriou, I. Boukovinas, V. Michalaki, 2022, AntiCancer Research.

Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study

S. Van Belle, T. Wheeler, A. Galid, 2012, Current medical research and opinion.

Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.

M. Dimopoulos, H. Gogas, G. Aravantinos, 2016, Clinical breast cancer.

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking

M. Özdoğan, E. Fountzilas, G. Theodoropoulos, 2023, Diagnostics.

S. Wetten, M. Wojtukiewicz, M. Šmakal, 2018, Supportive Care in Cancer.